| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.9M | +12.5% |
| Cost of Revenue | $5.1M | +14.2% |
| Gross Profit | -$204K | -82.1% |
| R&D Expense | $3.0M | -9.8% |
| SG&A Expense | $10.0M | -2.1% |
| Operating Income | -$13.3M | +3.3% |
| Pre-tax Income | -$27.0M | -28.0% |
| Income Tax | $35K | +333.3% |
| Net Income | -$27.0M | -28.2% |
| EPS (Basic) | -$0.75 | +74.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.5M | +7661.5% |
| Inventory | $7.3M | -10.0% |
| Current Assets | $20.7M | +111.7% |
| Total Assets | $22.5M | +86.3% |
| Current Liabilities | $18.7M | -47.1% |
| Total Liabilities | $18.8M | -47.7% |
| Stockholders' Equity | $3.8M | +108.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.7M | -32.0% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $27.1M | +130.6% |